Perioperative management of the patient with pheochromocytoma and Von Recklinghausen's disease
PDF (Español (España))
HTML (Español (España))

Keywords

Pheochromocytoma
Neurofibromatosis 1
Laparoscopy
Hemodynamic monitoring
Hypertension
Genetics
Perioperative Period

How to Cite

Molina Valencia, J. L., Barragán-Briceño, T., Restrepo-Moreno, M., Vásquez-Arango, J. ., & Toro-Vásquez, J. P. (2023). Perioperative management of the patient with pheochromocytoma and Von Recklinghausen’s disease. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 10(4). https://doi.org/10.53853/encr.10.4.805

Abstract

Introduction: In patients with neurofibromatosis type 1 the prevalence of pheochromocytoma is high, the risk of having a pheochromocytoma is 10 times higher than in the general population.

Objective: Describe the case of a patient with infrequent pathologies that requires the assistance of experts for its management before and in the follow-up after surgery.

Presentation of the case: Male, 38 years old with a history of NF1, evaluated for 4 months of headache, abdominal pain and difficult-to-control arterial hypertension. A diagnosis of pheochromocytoma was made and adrenalectomy was defined with perioperative hospitalization to control blood pressure levels with alpha and beta blockers.

Discussion: The management of pheochromocytoma is surgical resection. For the surgical procedure, patients must receive alpha blockade at least 10 days before the procedure and beta blockers 3 days before. Catecholamine crises can occur intraoperatively due to mechanical stress of the tumor. when being manipulated, psychological stress and medication.

Conclusion: Surgical treatment is the choice and must be performed by an interdisciplinary group to ensure adequate control of blood pressure figures in the perioperative period and thus avoid complications.

https://doi.org/10.53853/encr.10.4.805
PDF (Español (España))
HTML (Español (España))

References

Fishbein L. Pheochromocytoma/paraganglioma: is this a genetic disorder? Curr Cardiol Rep. 2019;21:104. https://doi.org/10.1007/s11886-019-1184-y

Zografos GN, Vasiliadis GK, Zagouri F, Aggeli C, Korkolis D, Vogiaki S, et al. Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends. World J Surg Oncol. 2010; 8:14. https://doi.org/10.1186/1477-7819-8-14

Vongsumran N, Kongkarnka S, Watanawittawas P, Manosroi W. Pheochromocytoma and gastrointestinal stromal tumours in an adult neurofibromatosis type 1 patient: a rare co-occurrence. BMJ Case Rep. 2020;13(6): e235129. https://doi.org/10.1136/bcr-2020-235129

Shahait A, Odisho T, Alshare B, Alghanem LJ, Weaver D. An unusual cause of adrenal mass in neurofibromatosis type 1: malignant peripheral nerve sheath tumor. Cureus. 2022; 14(1): e21782. https://doi.org/10.7759/cureus.21782

García-Agulló DO, Iriarte-Beroiz A, Rojo-Alvarado J, Munárriz P, Forga-Llenas L. Feocromocitoma familiar asociado a neurofibromatosis tipo 1. Endocrinol Nutr. 2013; 60(7):421-422.

Lee YH, Kwon MJ, Park JH, Jeong SJ, Kim TH, Jeong HW, et al. Neurofibromatosis type 1 with the development of pheochromocytoma and breast cancer. Intern Med. 2020; 59(13):1665-1669. https://doi.org/10.2169/internalmedicine.4148-19

Román-González A, Padilla-Zambrano H, Vásquez Jiménez LF. Perioperative management of pheocromocytoma/paraganglioma: a comprehensive review. Colomb J Anesthesiol. 2021; 49(3):e958. https://doi.org/10.5554/22562087.e958

Henriques-Vieira I, Almeida V, Moreno C, Paiva I. An uncommon presentation of pheochromocytoma in neurofibromatosis type 1 and the importance of long-term follow-up. Acta Med Port. 2023; 36(1):55-58. https://doi.org/10.20344/amp.16604

Theodosopoulou P, Nastos C, Paraskeva A. Anesthetic management of a patient with type 1 neuro?bromatosis and an occult pheochromocytoma: a case report. Braz J of Anesthesiol. 2023; 73(5):695-698. https://doi.org/10.1016/j.bjane.2021.02.045

Pan D, Liang P, Xiao H. Neurofibromatosis type 1 associated with pheochromocytoma and gastrointestinal stromal tumors: A case report and literature review. Oncol Lett. 2016; 12:637-643. https://doi.org/10.3892/ol.2016.4670

Bogus?awska A, Rzepka E, Opali?ska M, Sowa-Staszczak A, et al. A rare case of metastatic pheochromocytoma in the course of neurofibromatosis type 1. Pol Arch Intern Med. 2022; 132: 16291. https://doi.org/10.20452/pamw.16291

Román-González, A. Nuevos conceptos en feocromocitoma y paraganglioma en el 2017. Revista Colomb Endocrinología Diabetes Metab. 2017; 4(4): 19-23. https://doi.org/10.53853/encr.4.4.148

Zafar W, Chaucer B, Davalos F, Beenish S, Chevenon M, Nfonoyim J. Neurofibromatosis type 1 with a pheochromocytoma: A rare presentation of Von Recklinghausen disease. J Clin Endocrinol Metab. 2015; 5(5): 309-311. https://doi.org/10.14740/jem308w

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

Dimensions


PlumX


Downloads

Download data is not yet available.